NorthSea Therapeutics: NorthSea begins Phase I trial of liver disease asset in healthy volunteers

The final data from the Phase I trial recruiting 90 healthy participants is expected in the third quarter of 2022. The post NorthSea begins Phase I trial of liver disease asset in healthy volunteers appeared first on Clinical Trials Arena.